Necrostatin-1 Alleviates Lung Ischemia-Reperfusion Injury via Inhibiting Necroptosis and Apoptosis of Lung Epithelial Cells
Lung ischemia-reperfusion injury (LIRI) is associated with many diseases, including primary graft dysfunction after lung transplantation, and has no specific and effective therapies. Necroptosis contributes to the pathogenesis of ischemia-reperfusion injury. Necrostatin-1 (Nec-1), the necroptosis in...
Main Authors: | Lingjun Dong, Fuxiang Liang, Zhiling Lou, Yangfan Li, Jinsheng Li, Yaling Chen, Jingjing Ding, Bin Jiang, Chuanqiang Wu, Huan Yu, Yafei Liu, Weiping Zhang, Yunbi Lu, Ming Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/19/3139 |
Similar Items
-
Necrostatin-1: a promising compound for neurological disorders
by: Ke-qian Chen, et al.
Published: (2024-06-01) -
Necrostatin-1 attenuates early brain injury after subarachnoid hemorrhage in rats by inhibiting necroptosis
by: Chen F, et al.
Published: (2017-07-01) -
Effect of necrostatin-1 on sciatic nerve crush injury in rat models
by: Chen Yu, et al.
Published: (2023-01-01) -
RIP3‐mediated necroptosis increases neuropathic pain via microglia activation: necrostatin‐1 has therapeutic potential
by: Ping Fang, et al.
Published: (2021-10-01) -
Necrostatin-1 decreases necroptosis and inflammatory markers after intraventricular hemorrhage in mice
by: Chang Liu, et al.
Published: (2022-01-01)